West Syndrome: Response to valproate

Management of West syndrome is unsatisfactory. In our clinic we observed that a significant proportion of patients respond to usual dose of valproate. Objective: To prospectively assess the efficacy of valproate in controlling infantile spasms in West syndromeMethods: Consecutive patients presenting...

Full description

Bibliographic Details
Main Authors: Surabhi eChandra, Anupama eBhave, Roli eBhargava, Chandrakanta ekumar, Rashmi eKumar
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-11-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00166/full
_version_ 1811302930790219776
author Surabhi eChandra
Anupama eBhave
Roli eBhargava
Chandrakanta ekumar
Rashmi eKumar
author_facet Surabhi eChandra
Anupama eBhave
Roli eBhargava
Chandrakanta ekumar
Rashmi eKumar
author_sort Surabhi eChandra
collection DOAJ
description Management of West syndrome is unsatisfactory. In our clinic we observed that a significant proportion of patients respond to usual dose of valproate. Objective: To prospectively assess the efficacy of valproate in controlling infantile spasms in West syndromeMethods: Consecutive patients presenting with West syndrome to the Pediatric Neurology Clinic or general OPD were enrolled for study. Those who were not on any treatment were given valproate in a dose of 30 mg/kg/day while awaiting investigations. Patients were followed up every 2 weeks. Predefined criteria for definition of West syndrome and response were used. Those showing partial/poor response or relapse on valproate were given hormonal therapy.Results: One hundred children with West syndrome were enrolled. Ninety one children were started on valproate. Of these 36 (39.5%) showed a good response, but 7 later relapsed while on same dose of valproate and 3 were lost to follow up. Later age at onset and typical hypsarrythmia on EEG were associated with good sustained response to valproate while a history of delayed cry at birth was associated with partial or poor response. Sixty two patients who responded poorly to or relapsed on valproate were put on hormonal treatment in addition. Of these 36 (58.1%) had a good response but 11 later relapsed after stopping treatment and 2 were lost to follow up. Conclusions: Valproate may have a role in treatment of West syndrome in a selected group of patients.
first_indexed 2024-04-13T07:38:09Z
format Article
id doaj.art-8f9e3bb0584548a4becb526664f77816
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-13T07:38:09Z
publishDate 2012-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-8f9e3bb0584548a4becb526664f778162022-12-22T02:56:01ZengFrontiers Media S.A.Frontiers in Neurology1664-22952012-11-01310.3389/fneur.2012.0016636574West Syndrome: Response to valproateSurabhi eChandra0Anupama eBhave1Roli eBhargava2Chandrakanta ekumar3Rashmi eKumar4Chhatrapati Shahuji Maharaj Medical UniversityChhatrapati Shahuji Maharaj Medical UniversityChhatrapati Shahuji Maharaj Medical UniversityChhatrapati Shahuji Maharaj Medical UniversityChhatrapati Shahuji Maharaj Medical UniversityManagement of West syndrome is unsatisfactory. In our clinic we observed that a significant proportion of patients respond to usual dose of valproate. Objective: To prospectively assess the efficacy of valproate in controlling infantile spasms in West syndromeMethods: Consecutive patients presenting with West syndrome to the Pediatric Neurology Clinic or general OPD were enrolled for study. Those who were not on any treatment were given valproate in a dose of 30 mg/kg/day while awaiting investigations. Patients were followed up every 2 weeks. Predefined criteria for definition of West syndrome and response were used. Those showing partial/poor response or relapse on valproate were given hormonal therapy.Results: One hundred children with West syndrome were enrolled. Ninety one children were started on valproate. Of these 36 (39.5%) showed a good response, but 7 later relapsed while on same dose of valproate and 3 were lost to follow up. Later age at onset and typical hypsarrythmia on EEG were associated with good sustained response to valproate while a history of delayed cry at birth was associated with partial or poor response. Sixty two patients who responded poorly to or relapsed on valproate were put on hormonal treatment in addition. Of these 36 (58.1%) had a good response but 11 later relapsed after stopping treatment and 2 were lost to follow up. Conclusions: Valproate may have a role in treatment of West syndrome in a selected group of patients.http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00166/fullhormonal therapyTreatmentinfantile spasmsWest syndromepredictors
spellingShingle Surabhi eChandra
Anupama eBhave
Roli eBhargava
Chandrakanta ekumar
Rashmi eKumar
West Syndrome: Response to valproate
Frontiers in Neurology
hormonal therapy
Treatment
infantile spasms
West syndrome
predictors
title West Syndrome: Response to valproate
title_full West Syndrome: Response to valproate
title_fullStr West Syndrome: Response to valproate
title_full_unstemmed West Syndrome: Response to valproate
title_short West Syndrome: Response to valproate
title_sort west syndrome response to valproate
topic hormonal therapy
Treatment
infantile spasms
West syndrome
predictors
url http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00166/full
work_keys_str_mv AT surabhiechandra westsyndromeresponsetovalproate
AT anupamaebhave westsyndromeresponsetovalproate
AT roliebhargava westsyndromeresponsetovalproate
AT chandrakantaekumar westsyndromeresponsetovalproate
AT rashmiekumar westsyndromeresponsetovalproate